Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
216 hedge funds and large institutions have $882M invested in Immunogen Inc in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 81 reducing their positions, and 23 closing their positions.
378% more call options, than puts
Call options by funds: $4.36M | Put options by funds: $912K
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
0% less funds holding
Funds holding: 217 → 216 (-1)
4% less capital invested
Capital invested by funds: $922M → $882M (-$39.6M)
23% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 81
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$50.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.5M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$12M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7M |
| 5 |
Millennium Management
New York
|
+$6.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$7.91M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$7.35M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$5.52M |
IMGN Hedge Fund Activity: Q2 2022 in Review
216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2022, worth a combined $882M — down 4.3% from $922M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new IMGN positions and 23 closed out — a net gain of 2 holders — while 62 added to existing stakes and 81 trimmed.
The largest buyer was Deerfield Management, adding an estimated $50.2M. The largest seller was Fidelity Investments, cutting an estimated $47.7M.
- 216 institutional investors held Immunogen Inc (IMGN) as of Q2 2022, down from 217 in Q1 2022.
- Funds reported $882M of Immunogen Inc stock for Q2 2022, down 4.3% quarter-over-quarter.
- 25 funds opened new Immunogen Inc positions in Q2 2022 and 23 closed out, a net change of +2 holders.
- The largest Immunogen Inc buyer in Q2 2022 was Deerfield Management, an estimated $50.2M added.
- The largest Immunogen Inc seller in Q2 2022 was Fidelity Investments, an estimated $47.7M sold.
Based on aggregated 13F filings for Q2 2022.